Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
TENM2 antisense RNA 1 (TENM2-AS1)
- Target
- TENM2-AS1
- Molecular classification
- Long non-coding RNA (lncRNA), Antisense RNA, Other (non-protein-coding RNA)
01
Overview
TENM2 antisense RNA 1 (TENM2-AS1) is a long, antisense non-coding RNA gene that is oriented opposite to the protein-coding TENM2 gene. Like other antisense lncRNAs, TENM2-AS1 is thought to potentially regulate the expression of its sense (TENM2) gene partner by mechanisms such as transcriptional interference, RNA-RNA binding, or epigenetic modification, but its distinct biological functions, mechanisms, and disease associations remain largely uncharacterized in available literature and major databases. No direct evidence currently supports TENM2-AS1 as a therapeutic target or as a clinically relevant biomarker.
- Other names
- sometimes described only as an antisense lncRNA for TENM2
02
Mechanism of action
None known. Generally, antisense lncRNAs can be modulated by antisense oligonucleotides (ASOs) or siRNAs, but specific mechanisms for TENM2-AS1 have not been documented.
03
Biological functions
Modulation of gene expression (by antisense mechanism)Potential epigenetic regulationOther (typical lncRNA functions, such as chromatin modification or transcriptional interference, inferred by analogy to other antisense lncRNAs, but specific functions for TENM2-AS1 are not fully described in current literature)
04
Disease associations
Other (No direct evidence for association with specific diseases. Antisense lncRNAs are sometimes studied in cancer, metabolism, or neurodevelopment, but no direct data for TENM2-AS1 found in current sources.)
Beyond the preview
Go deeper on TENM2 antisense RNA 1 (TENM2-AS1).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on TENM2 antisense RNA 1 (TENM2-AS1).